Bruker
BRKR· Manufacturing· Fiscal year ends in December
Frank H. Laukien, Ph.D. is the CEO of Bruker and was paid $4.7M in FY2025 (Dec), down 15%.
Executives5
See all- 1Frank H. Laukien, Ph.D.Chairman, President and Chief Executive OfficerFY2025
- 2Mark R. Munch, Ph.D.Executive Vice President & President, Bruker NANO GroupFY2025
- 3Gerald N. HermanExecutive Vice President and Chief Financial OfficerFY2025
- 4Juergen W. SregaPresident, Bruker CALID GroupFY2025
- 5Falko BussePh.D. President, Bruker BioSpin GroupFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allBruker paid its 5 named executives $11.7M in total in FY2025 (Dec). CEO Falko Busse was paid $1.4M of that.
| Name | |||
|---|---|---|---|
| Frank H. Laukien, Ph.D.Chairman, President and Chief Executive Officer | |||
| Mark R. Munch, Ph.D.Executive Vice President & President, Bruker NANO Group | |||
| Gerald N. HermanExecutive Vice President and Chief Financial Officer | |||
| Juergen W. SregaPresident, Bruker CALID Group | |||
| Falko BussePh.D. President, Bruker BioSpin Group |
of each named executive, from the Summary Compensation Table of each proxy.
Peers15
See allThe FY2025 (Dec) proxy of Bruker names 15 peer companies for pay. Among Bruker and these peers, CEO pay was the lowest of 11 and total shareholder return was 6th highest of 11.
11th highest of 11in Bruker and its pay peers, FY2025 (Dec) by CEO pay:
6th highest of 11in Bruker and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 10, 2026 | FY2025 |
| Annual report | 10-K | Feb 27, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 11, 2025 | FY2024 |
| Annual report | 10-K | Mar 3, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 19, 2024 | FY2023 |
| Annual report | 10-K | Feb 29, 2024 | FY2023 |